Innate Pharma S.A. Statistics Share Statistics Innate Pharma S.A. has 84.24M
shares outstanding. The number of shares has increased by 13.85%
in one year.
Shares Outstanding 84.24M Shares Change (YoY) 13.85% Shares Change (QoQ) 9.96% Owned by Institutions (%) 0.2% Shares Floating 59.22M Failed to Deliver (FTD) Shares 94 FTD / Avg. Volume 0.72%
Short Selling Information The latest short interest is 46.37K, so 0.05% of the outstanding
shares have been sold short.
Short Interest 46.37K Short % of Shares Out 0.05% Short % of Float 0.06% Short Ratio (days to cover) 3.72
Valuation Ratios The PE ratio is -2.91 and the forward
PE ratio is -2.98.
Innate Pharma S.A.'s PEG ratio is
-0.01.
PE Ratio -2.91 Forward PE -2.98 PS Ratio 11.41 Forward PS 8.1 PB Ratio 16.3 P/FCF Ratio -19.76 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Innate Pharma S.A..
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.6,
with a Debt / Equity ratio of 3.51.
Current Ratio 2.6 Quick Ratio 2.6 Debt / Equity 3.51 Debt / EBITDA -0.66 Debt / FCF -4.25 Interest Coverage -91.12
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $69.73K Profits Per Employee $-273.32K Employee Count 181 Asset Turnover 0.11 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -18.64% in the
last 52 weeks. The beta is 0.91, so Innate Pharma S.A.'s
price volatility has been higher than the market average.
Beta 0.91 52-Week Price Change -18.64% 50-Day Moving Average 2.07 200-Day Moving Average 2 Relative Strength Index (RSI) 31.89 Average Volume (20 Days) 13,142
Income Statement In the last 12 months, Innate Pharma S.A. had revenue of 12.62M
and earned -49.47M
in profits. Earnings per share was -0.61.
Revenue 12.62M Gross Profit 12.62M Operating Income -51.58M Net Income -49.47M EBITDA -46.91M EBIT -48.91M Earnings Per Share (EPS) -0.61
Full Income Statement Balance Sheet The company has 66.4M in cash and 31M in
debt, giving a net cash position of 35.4M.
Cash & Cash Equivalents 66.4M Total Debt 31M Net Cash 35.4M Retained Earnings -386.36M Total Assets 111.06M Working Capital 52.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.9M
and capital expenditures -391K, giving a free cash flow of -7.29M.
Operating Cash Flow -6.9M Capital Expenditures -391K Free Cash Flow -7.29M FCF Per Share -0.09
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -408.64% and -391.97%.
Gross Margin 100% Operating Margin -408.64% Pretax Margin -391.97% Profit Margin -391.97% EBITDA Margin -371.69% EBIT Margin -408.64% FCF Margin -57.74%
